Professional
Added to YB: 2026-01-07
Pitch date: 2026-01-05
ILMN [bullish]
Illumina, Inc.
+3.07%
current return
Author Info
Idea Brunch is an interview series where great off-the-beaten-path investors share their best ideas and insights about their research process. Yellowbrick users get a 20% discount for life
Company Info
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
Market Cap
$22.9B
Pitch Price
$141.48
Price Target
N/A
Dividend
N/A
EV/EBITDA
19.42
P/E
33.66
EV/Sales
5.65
Sector
Life Sciences Tools and Services
Category
turnaround
Idea Brunch with Jon Hartman and Jim Burke of Hartman Burke Capital Management - Illumina, Inc.
ILMN: Genomic sequencing leader down 70% from peak due to NovaSeq X pricing transition (~60% consumables price cuts). Pricing headwind inflecting positive as transition >50% complete. New CEO Jacob Thaysen driving 300bp margin improvement. FDA approved Guardant Shield blood cancer screening unlocks $50B opportunity. Expects accelerating revenue growth as liquid biopsy market materializes.
Read full article (3 min)